Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Fernando Ulloa Montoya"'
Autor:
Andrew Wilber, Fernando Ulloa Montoya, Luke Hammer, Branden S. Moriarity, Aron M. Geurts, David A. Largaespada, Catherine M. Verfaillie, R. Scott McIvor, Uma Lakshmipathy
Publikováno v:
Stem Cells International, Vol 2011 (2011)
Non-viral integrating systems, PhiC31 phage integrase (ϕC31), and Sleeping Beauty transposase (SB), provide an effective method for ex vivo gene delivery into cells. Here, we used a plasmid-encoding GFP and neomycin phosphotransferase along with rec
Externí odkaz:
https://doaj.org/article/db48085b129a49e08c0edd2a02e48100
Autor:
Kelly E. Seaton, Rachel L. Spreng, Milite Abraha, Matthew Reichartz, Michelle Rojas, Frederick Feely, Richard H. C. Huntwork, Sheetij Dutta, Sarah V. Mudrak, S. Munir Alam, Scott Gregory, Erik Jongert, Margherita Coccia, Fernando Ulloa-Montoya, Ulrike Wille-Reece, Georgia D. Tomaras, S. Moses Dennison
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-13 (2021)
Abstract RTS,S/AS01 is an advanced pre-erythrocytic malaria vaccine candidate with demonstrated vaccine efficacy up to 86.7% in controlled human malaria infection (CHMI) studies; however, reproducible immune correlates of protection (CoP) are elusive
Externí odkaz:
https://doaj.org/article/0219a60f06354a4495a0f6088c161287
Autor:
William Chad Young, Lindsay N. Carpp, Sidhartha Chaudhury, Jason A. Regules, Elke S. Bergmann-Leitner, Christian Ockenhouse, Ulrike Wille-Reece, Allan C. deCamp, Ellis Hughes, Celia Mahoney, Suresh Pallikkuth, Savita Pahwa, S. Moses Dennison, Sarah V. Mudrak, S. Munir Alam, Kelly E. Seaton, Rachel L. Spreng, Jon Fallon, Ashlin Michell, Fernando Ulloa-Montoya, Margherita Coccia, Erik Jongert, Galit Alter, Georgia D. Tomaras, Raphael Gottardo
Publikováno v:
Frontiers in Big Data, Vol 4 (2021)
RTS,S/AS01 (GSK) is the world’s first malaria vaccine. However, despite initial efficacy of almost 70% over the first 6 months of follow-up, efficacy waned over time. A deeper understanding of the immune features that contribute to RTS,S/AS01-media
Externí odkaz:
https://doaj.org/article/3a278326c7e94b59825dbc56352b388d
Autor:
Fernando Ulloa-Montoya, Jamila Louahed, Vincent G. Brichard, Bart Spiessens, Channa Debruyne, Patrick Therasse, Fawn Wang, Susana Salceda, Hans van Houwelingen, Jelle Goeman, Djordje Atanackovic, Lecia V. Sequist, Johan F. Vansteenkiste, John M. Kirkwood, Helen J. Gogas, Peter Hersey, Brigitte Dreno, Muriel Debois, Andrea Callegaro, Benjamin Dizier
Supplementary material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5528f31009db1e47f0a2c403009ea8f6
https://doi.org/10.1158/1078-0432.22473330.v1
https://doi.org/10.1158/1078-0432.22473330.v1
Autor:
Fernando Ulloa-Montoya, Jamila Louahed, Vincent G. Brichard, Bart Spiessens, Channa Debruyne, Patrick Therasse, Fawn Wang, Susana Salceda, Hans van Houwelingen, Jelle Goeman, Djordje Atanackovic, Lecia V. Sequist, Johan F. Vansteenkiste, John M. Kirkwood, Helen J. Gogas, Peter Hersey, Brigitte Dreno, Muriel Debois, Andrea Callegaro, Benjamin Dizier
Purpose:Immune components of the tumor microenvironment (TME) have been associated with disease outcome. We prospectively evaluated the association of an immune-related gene signature (GS) with clinical outcome in melanoma and non–small cell lung c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba2c738c013635e68f3f047ad124642
https://doi.org/10.1158/1078-0432.c.6528486
https://doi.org/10.1158/1078-0432.c.6528486
Autor:
Erik Jongert, Richard H. C. Huntwork, S. Munir Alam, Milite Abraha, Sheetij Dutta, S. Moses Dennison, Rachel L. Spreng, Matthew Reichartz, Sarah V. Mudrak, Fernando Ulloa-Montoya, Georgia D. Tomaras, Michelle Rojas, Scott Gregory, Ulrike Wille-Reece, Margherita Coccia, Kelly E. Seaton, Frederick Feely
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-13 (2021)
npj Vaccines, Vol 6, Iss 1, Pp 1-13 (2021)
RTS,S/AS01 is an advanced pre-erythrocytic malaria vaccine candidate with demonstrated vaccine efficacy up to 86.7% in controlled human malaria infection (CHMI) studies; however, reproducible immune correlates of protection (CoP) are elusive. To iden
Autor:
Vanesa Bol, Robert A. van den Berg, Emilio Siena, Laurane De Mot, Wivine Burny, Ahmed Essaghir, Viviane Bechtold, Andrea Callegaro, Age K. Smilde, Dicle Hasdemir, Fernando Ulloa-Montoya, Margherita Coccia, Arnaud M. Didierlaurent, Robbert van der Most
Publikováno v:
Science translational medicine, 12(569):eaay8618. American Association for the Advancement of Science
The current routine use of adjuvants in human vaccines provides a strong incentive to increase our understanding of how adjuvants differ in their ability to stimulate innate immunity and consequently enhance vaccine immunogenicity. Here, we evaluated
Autor:
Benjamin Dizier, Andrea Callegaro, Robert M. Conry, Jean-Jacques Grob, Vincent Brichard, Laurent Machet, John F. Thompson, Evgeny Levchenko, Kamil Drucis, Mario Santinami, Gabriela Cinat, Sergii Korovin, John M. Kirkwood, Jaroslaw Jaroszek, Wim H. J. Kruit, Brigitte Dréno, Hans C. van Houwelingen, Bernard Guillot, Axel Hauschild, Jelle J. Goeman, Thomas Jouary, Peter Hersey, Ralf Gutzmer, Susana Puig, P. Therasse, Bernard Mark Smithers, Florent Grange, Bart Spiessens, Channa Debruyne, Piotr Rutkowski, Lev V. Demidov, Alessandro Testori, Igor Bondarenko, Muriel Debois, Fernando Ulloa-Montoya, Jamila Louahed, Ivana Krajsová, John A. Thompson
Publikováno v:
The Lancet Oncology
The Lancet Oncology, 19(7), 916-929
Lancet Oncology
Lancet Oncology, Elsevier, 2018, 19 (7), pp.916--929. ⟨10.1016/S1470-2045(18)30254-7⟩
Lancet Oncology, 19(7), 916-929. Lancet Publishing Group
The Lancet Oncology, 19(7), 916-929
Lancet Oncology
Lancet Oncology, Elsevier, 2018, 19 (7), pp.916--929. ⟨10.1016/S1470-2045(18)30254-7⟩
Lancet Oncology, 19(7), 916-929. Lancet Publishing Group
International audience; BACKGROUND: Despite newly approved treatments, metastatic melanoma remains a life-threatening condition. We aimed to evaluate the efficacy of the MAGE-A3 immunotherapeutic in patients with stage IIIB or IIIC melanoma in the ad
Autor:
Miriam Huls, Joost P. H. Schoeber, Catherine M. Verfaillie, Aernout Luttun, Fernando Ulloa-Montoya, Aswin L. Menke, Lars R. Van Bolderen, Rob M. Woestenenk, Gerard F. M. Merkx, Jack F. M. Wetzels, Frans G. M. Russel, Rosalinde Masereeuw Ph.D.
Publikováno v:
Cell Transplantation, Vol 19 (2010)
Externí odkaz:
https://doaj.org/article/03275398f80c49ff9614e3c980e11c48
Autor:
Benjamin Dizier, Fernando Ulloa Montoya, Andrea Callegaro, Hans C. van Houwelingen, Bart Spiessens
Publikováno v:
Biometrical Journal. 59:672-684
In this paper, we considered different methods to test the interaction between treatment and a potentially large number (p) of covariates in randomized clinical trials. The simplest approach was to fit univariate (marginal) models and to combine the